These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 21466776)

  • 1. [Level of evidence for therapeutic drug monitoring of aminoglycosides].
    Venisse N; Boulamery A;
    Therapie; 2011; 66(1):39-44. PubMed ID: 21466776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Level of evidence for therapeutic drug monitoring of teicoplatin].
    Boulamery A; Venisse N; Le Guellec C;
    Therapie; 2011; 66(1):45-50. PubMed ID: 21466777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Level of evidence for therapeutic drug monitoring of vancomycin].
    Jelassi ML; Benlmouden A; Lefeuvre S; Mainardi JL; Billaud EM;
    Therapie; 2011; 66(1):29-37. PubMed ID: 21466775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Not Available].
    Venisse N; Boulamery A;
    Therapie; 2011; 66(1):39-44. PubMed ID: 27393463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cost-effectiveness analysis of active TDM in elderly patients treated with aminoglycosides].
    Leon-Djian CB; Bourguignon L; Späth HM; Maire P
    Therapie; 2011; 66(5):445-52. PubMed ID: 22031689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring.
    Croes S; Koop AH; van Gils SA; Neef C
    Eur J Pharm Sci; 2012 Jan; 45(1-2):90-100. PubMed ID: 22094306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Which partner for the betalactam agent in empirical combined therapy? II. Aminoglycoside].
    Mimoz O; Grollier G
    Ann Fr Anesth Reanim; 2004 Jun; 23(6):639-42. PubMed ID: 15234735
    [No Abstract]   [Full Text] [Related]  

  • 8. Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity.
    Avent ML; Rogers BA; Cheng AC; Paterson DL
    Intern Med J; 2011 Jun; 41(6):441-9. PubMed ID: 21309997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aminoglycoside antibiotics].
    Kubo H; Shinozaki K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():427-31. PubMed ID: 15658355
    [No Abstract]   [Full Text] [Related]  

  • 10. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, Poland--part II.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):491-5. PubMed ID: 16583990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, poland--part I.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):485-90. PubMed ID: 16583989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aminoglycosides are effective--but oto- and nephrotoxic. Knowledge base from the reference group for antibiotic issues on benefit-risk with aminoglycosides].
    Ternhag A; Giske CG; Hanberger H
    Lakartidningen; 2014 Feb 12-18; 111(7):268-9. PubMed ID: 24669487
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic drug monitoring of aminoglycosides in neonates.
    Touw DJ; Westerman EM; Sprij AJ
    Clin Pharmacokinet; 2009; 48(2):71-88. PubMed ID: 19271781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aminoglycosides and polymyxins].
    Molina J; Cordero E; Palomino J; Pachón J
    Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):178-88. PubMed ID: 19303668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycosides: a practical review.
    Gonzalez LS; Spencer JP
    Am Fam Physician; 1998 Nov; 58(8):1811-20. PubMed ID: 9835856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglycoside therapy in infectious diseases.
    Poulikakos P; Falagas ME
    Expert Opin Pharmacother; 2013 Aug; 14(12):1585-97. PubMed ID: 23746121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Back to the future: using aminoglycosides again and how to dose them optimally.
    Drusano GL; Ambrose PG; Bhavnani SM; Bertino JS; Nafziger AN; Louie A
    Clin Infect Dis; 2007 Sep; 45(6):753-60. PubMed ID: 17712761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.
    Prescott WA; Nagel JL
    Pharmacotherapy; 2010 Jan; 30(1):95-108. PubMed ID: 20030477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Level of evidence for therapeutic drug monitoring of ceftriaxone].
    Dailly E; Verdier MC; Deslandes G; Bouquié R; Tribut O; Bentué-Ferrer D
    Therapie; 2012; 67(2):145-9. PubMed ID: 22850101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is therapeutic drug monitoring (TDM) in paediatric patients necessary?].
    Prokopczyk J; Piekarczyk A; Kaminska E
    Med Wieku Rozwoj; 2001; 5(2):149-55. PubMed ID: 11679679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.